UDP-003
Asset
Captures and removes toxic oxidized cholesterol to restore macrophage function and reduce arterial plaque.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Atherosclerosis
Phase 1, cyclaritytx.com, 10 Oct 2026
Neurodegenerative disease
Phase 1, cyclaritytx.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors6
Every asset’s record: target, stage, trials and the evidence behind it.